Hydralazine therapy in idiopathic sle

Orogenital ulcers, SLE and hydralazine.

The case is reported of a man developing drug-induced systemic lupus erythematosus while taking hydralazine. The illness was characterized by arthritis and a purpuric rash particularly in the light-sensitive areas as well as orogenital and cutaneous ulceration. Anti-nuclear antibody and DNA binding were positive. All clinical manifestations disappeared on withdrawal of hydralazine.

Idiopathic Thrombocytopenic Purpura Masquerading Paediatric SLE

1. Halliday RB, OConnor BM, Baker AS. “Global Diversity of Mites”. In Peter H. Raven and Tania Williams. Nature and human society: The quest for a sustainable world: Proceedings of the 1997 Forum on Biodiversity. Washington DC: National Academies; 2000. p. 192-212. 2. Ralph GP. Effects of the haematophagous mite Ornithonyssus bursa on nestling starlings in New Zealand. New Zealand J Zool 1977;4...

Combined Rauwolfia-hydralazine therapy of hypertensive patients.

Oral hydralazine therapy for chronic refractory heart failure.

The hemodynamic effects of oral hydralazine were investigated in ten patients (nine in NYHA Class IV and one in Class III) with chronic refractory heart failure. With hemodynamic monitoring, adequate oral doses of hydralazine (50 or 75 mg) were determined and then administered every six hours. Hemodynamics were determined at 2-3, 6-8 and 24 hours on hydralazine therapy. Arterial pressure decrea...

Antioxidant therapy in idiopathic oligoasthenoteratozoospermia

INTRODUCTION Idiopathic oligoasthenoteratozoospermia (iOAT) is commonly encountered during the evaluation of men with infertility. Antioxidants have been utilized empirically in the treatment of iOAT based on their ability to reverse oxidative stress (OS)-induced sperm dysfunction often encountered in this patient population. METHODS A literature search was performed using MEDLINE/PubMed, foc...